Biotech

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Imugene HER2 vaccine hits target in stomach cancer trial

A peptide vaccine developed by Australia's Imugene has reduced tumour size in around half of patients with HER2-positive gastric or gastroesophageal junction (GEJ) cancer in a phase 2 trial

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK biotech 'booming' as sector rakes in £1.6bn in Q2 financi...

The UK's biotechnology sector is going through a purple patch, attracting almost £1.6 billion ($2.2 billion) in financing in the three months to end-May – which is a record for the industry

R&D

Pharma’s use of synthetic biology could deliver radical inno...

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe.

Events